France Sleep Apnea Devices Market size was valued at USD 250.70 million in 2018, reached USD 377.95 million in 2024, and is anticipated to reach USD 650.25 million by 2032, at a CAGR of 6.53% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
France Quartz Countertops Market Size 2024
USD 377.95 Million
France Quartz Countertops Market, CAGR
6.53%
France Quartz Countertops Market Size 2032
USD 650.25 Million
The France Sleep Apnea Devices Market is shaped by strong competition among global and domestic players, with ResMed France and Philips Respironics France leading through advanced PAP systems and cloud-connected solutions. SomnoMed France and BMC Medical France strengthen the therapeutic portfolio with oral appliances and cost-effective devices, while Inspire Medical Systems France focuses on implantable neurostimulation therapies. Löwenstein Medical France and LivaNova PLC France enhance diagnostic and therapeutic adoption, supported by established clinical networks. Sicat France, Drive DeVilbiss France, and Zephyr Sleep Technologies France contribute with innovative masks, wearables, and digital solutions. Southern France leads regionally with 34% market share in 2024, driven by advanced healthcare infrastructure, strong diagnostic capacity, and widespread adoption of connected treatment technologies.
Market Insights
The France Sleep Apnea Devices Market grew from USD 250.70 million in 2018 to USD 377.95 million in 2024 and is expected to reach USD 650.25 million by 2032.
Therapeutic devices dominated with 62% share in 2024, led by Positive Airway Pressure (PAP) devices, supported by physician preference and expanding home-based treatment options.
Diagnostic devices held 25% share in 2024, with Polysomnography (PSG) devices leading, while Home Sleep Test (HST) kits gained traction due to convenience and lower costs.
Hospitals and clinics captured 48% share in 2024, supported by advanced diagnostic facilities, while home care settings expanded rapidly with rising adoption of portable PAP devices.
Southern France led regionally with 34% share in 2024, driven by advanced medical facilities, higher diagnosis rates, and strong adoption of connected health technologies.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Therapeutic devices dominate the France Sleep Apnea Devices Market, holding nearly 62% share in 2024. Within this category, Positive Airway Pressure (PAP) devices lead due to their proven effectiveness in managing obstructive sleep apnea. Rising diagnosis rates and physician preference for PAP therapy drive adoption. Oral appliances and nasal masks also contribute steadily, supported by demand for less invasive options. Expanding home-based treatment, coupled with innovation in mask design, strengthens the therapeutic devices segment’s long-term market position.
For instance, ResMed introduced the AirFit F40 full-face mask in Europe, designed with a smaller seal and soft silicone cushion to improve patient comfort and adherence.
By Diagnostic Devices
Diagnostic devices account for around 25% share in 2024, with Polysomnography (PSG) devices leading as the gold standard in sleep testing. PSG adoption is supported by widespread use in hospitals and specialized sleep laboratories. However, Home Sleep Test (HST) kits are gaining traction due to their convenience and lower cost, particularly among patients preferring at-home diagnosis. The shift toward portable diagnostic tools, combined with growing awareness of sleep disorders, enhances segment growth and supports early detection.
For instance, Itamar Medical reported increased global adoption of its WatchPAT ONE disposable HST device, reflecting rising preference for portable diagnostic tools that facilitate early detection and broader patient reach.
By End User
Hospitals and clinics represent the largest end-user segment, capturing about 48% share in 2024. Strong infrastructure, advanced diagnostic facilities, and reimbursement support reinforce their dominance. Sleep laboratories maintain a vital role in offering in-depth testing, while the home care setting is expanding rapidly, driven by the rising use of portable PAP devices and HST kits. Increasing patient preference for convenient and cost-effective care at home supports this trend, creating growth opportunities for manufacturers targeting individual users.
Key Growth Drivers
Rising Prevalence of Sleep Apnea
The growing prevalence of sleep apnea in France is a significant driver of device adoption. An aging population, obesity, and lifestyle-related risk factors continue to increase the diagnosed patient pool. Higher awareness among both patients and healthcare providers accelerates screening and early intervention. Hospitals, clinics, and sleep laboratories report steady increases in diagnosis volumes, which directly support higher demand for therapeutic devices such as PAP systems and oral appliances. This trend ensures consistent growth for the market over the forecast period.
For instance, Löwenstein Medical expanded its PrismaLINE PAP device portfolio in 2023, tailoring therapy options to European clinical requirements, including sleep laboratories and hospitals in France.
Expansion of Home-Based Treatment
The shift toward home-based care strongly supports market growth in France. Patients increasingly prefer portable PAP devices, home sleep test kits, and remote monitoring solutions that enable treatment outside hospitals. The convenience, cost-effectiveness, and privacy of home management improve therapy adherence and satisfaction. Insurance coverage and government focus on reducing hospital burden further strengthen this shift. As device manufacturers launch compact, user-friendly products, the adoption of homecare solutions is expected to accelerate, expanding access and supporting long-term revenue growth.
For instance, Koninklijke Philips launched its NightBalance device, a non-invasive positional therapy solution tailored for at-home use, in select countries including the United States, United Kingdom, Austria, Germany, Switzerland, Belgium, the Netherlands, and Luxembourg.
Technological Advancements in Devices
Continuous innovation in sleep apnea devices enhances their effectiveness, comfort, and usability. Advanced PAP machines with auto-adjusting pressure, quiet operation, and cloud connectivity improve patient compliance. Oral appliances are becoming more customized, while masks are designed for greater comfort and reduced leakage. Diagnostic tools such as portable PSG devices and wearable sensors offer more efficient testing and faster results. These advancements not only expand product adoption but also encourage replacement purchases, ensuring that technological upgrades remain a strong growth driver.
Key Trends & Opportunities
Integration of Digital Health Solutions
Digital connectivity is becoming a major trend in France’s sleep apnea devices market. Cloud-based platforms and mobile applications allow real-time data sharing between patients and physicians. This integration supports better monitoring, timely intervention, and improved adherence rates. Manufacturers are leveraging artificial intelligence to analyze sleep patterns, optimize therapy, and personalize treatment. The growing acceptance of telehealth and digital healthcare ecosystems presents an opportunity for companies to strengthen their offerings, build stronger relationships with patients, and drive competitive differentiation in the market.
For instance, SENSAPNEA offers a home-use diagnosis solution using a chin sensor paired with a mobile app and cloud-based platform, allowing seamless communication between patients and physicians, which enhances care access and management.
Growing Demand for Customized and Comfortable Masks
Patient comfort is increasingly shaping purchasing decisions for sleep apnea devices. Demand for lightweight, flexible, and customizable nasal and full-face masks is rising in France. Manufacturers are investing in advanced materials, ergonomic designs, and improved airflow systems to reduce discomfort and leakage. The opportunity lies in catering to diverse patient needs, from mild to severe apnea cases, through tailored mask solutions. As adherence strongly depends on comfort, this trend supports both higher compliance and broader adoption, creating strong growth potential.
For instance, Fisher & Paykel Healthcare expanded its Evora Full mask line, which incorporates headgear technologies designed for stability and freedom of movement, improving comfort for long-term use.
Key Challenges
Low Diagnosis and Treatment Rates
Despite increasing awareness, underdiagnosis remains a key challenge in the French market. Many patients with mild to moderate sleep apnea go untreated due to lack of awareness, misdiagnosis, or reluctance to undergo testing. Limited outreach in rural areas and social stigma associated with sleep disorders further reduce treatment rates. This gap in diagnosis slows market penetration for both diagnostic and therapeutic devices. Addressing this challenge requires targeted awareness campaigns, broader access to screening, and improved patient education.
High Cost of Advanced Devices
The cost of advanced sleep apnea devices remains a barrier, particularly for uninsured or underinsured patients. While hospitals and clinics invest in high-end PSG systems and advanced PAP devices, affordability limits adoption in homecare settings. Reimbursement frameworks do not always cover the latest technologies, restricting patient access. This challenge affects penetration of innovative solutions in lower-income groups. Manufacturers need to balance innovation with affordability and work with policymakers to ensure reimbursement systems adapt to evolving device offerings.
Compliance and Adherence Issues
Poor patient compliance continues to hinder the effectiveness of sleep apnea treatment in France. Many patients discontinue PAP therapy due to discomfort, mask leakage, noise, or lifestyle inconvenience. Oral appliances and other alternatives face similar adherence issues. Non-compliance not only reduces clinical outcomes but also impacts replacement sales and long-term market growth. Device makers are focusing on comfort-driven designs, education programs, and digital monitoring to address this barrier, but adherence remains a significant challenge for market expansion.
Regional Analysis
Northern France
Northern France accounted for 21% share in 2024, supported by strong healthcare infrastructure and the presence of specialized sleep centers in metropolitan areas such as Lille. The region benefits from rising awareness campaigns and government-backed diagnostic programs. Hospitals and clinics dominate adoption, while home care devices are gradually gaining momentum. Local demand for PAP devices remains strong, driven by increasing diagnosis rates. The France Sleep Apnea Devices Market in this region shows steady growth, supported by investments in digital health solutions and expanding patient outreach.
Southern France
Southern France held the largest share at 34% in 2024, driven by advanced medical facilities and higher diagnosis rates. Cities such as Marseille and Lyon serve as key hubs for specialized treatment centers and sleep laboratories. The region benefits from strong adoption of therapeutic devices, particularly PAP systems and customized masks. Home sleep testing is expanding rapidly due to patient preference for convenience. It continues to attract significant investments in connected health technologies, making Southern France a leader in sleep apnea device adoption and usage.
Western France
Western France represented 19% share in 2024, supported by growing investments in healthcare infrastructure across cities like Nantes and Rennes. The region shows rising demand for diagnostic devices, particularly PSG systems and home test kits. Hospitals and clinics remain the leading end users, while home-based care adoption is growing with increased awareness. Oral appliances are gaining traction in this region, appealing to patients seeking non-invasive solutions. It demonstrates stable growth supported by expanding healthcare accessibility and targeted awareness programs on sleep disorders.
Eastern France
Eastern France captured 16% share in 2024, with Strasbourg and nearby cities emerging as important centers for diagnostic and therapeutic solutions. Strong cross-border healthcare collaborations with Germany drive innovation adoption. Sleep laboratories dominate usage, while portable PAP devices are recording rising demand in homecare settings. The market here is supported by favorable reimbursement policies and wider insurance coverage. The France Sleep Apnea Devices Market in Eastern France benefits from both public and private initiatives that improve access to advanced treatment technologies.
Central France
Central France accounted for 10% share in 2024, marking the smallest regional contribution. Limited healthcare infrastructure and lower diagnosis rates restrict growth compared to other regions. However, adoption of home sleep test kits and portable PAP devices is increasing as awareness improves. Regional hospitals and clinics are focusing on expanding diagnostic facilities to meet growing demand. Patient outreach programs and collaborations with national health agencies aim to improve accessibility. It is expected to gradually strengthen its role in the overall market growth.
Market Segmentations:
By Product Type
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Appliances
Oxygen Therapy Devices
Nasal & Full-Face Masks
Others
Diagnostic Devices
Polysomnography (PSG) Devices
Home Sleep Test Kits (HST)
Pulse Oximeters
Actigraphy Wearables
Others
Sleep Apnea Masks
By End User
Hospitals and Clinics
Sleep Laboratories
Home Care Settings / Individual Users
Others
By Region
Northern France
Southern France
Western France
Eastern France
Central France
Competitive Landscape
The France Sleep Apnea Devices Market is characterized by strong competition between global leaders and domestic players, each aiming to strengthen their presence through innovation and strategic expansion. ResMed France and Philips Respironics France lead the market with advanced PAP devices, cloud-connected solutions, and broad distribution networks. SomnoMed France and BMC Medical France compete by offering oral appliances and cost-effective therapeutic options, appealing to patients seeking alternatives to traditional PAP therapy. Inspire Medical Systems France focuses on implantable neurostimulation devices, addressing patients with severe obstructive sleep apnea who fail conventional therapies. Löwenstein Medical France and LivaNova PLC France play vital roles in diagnostic and therapeutic equipment supply, supported by strong clinical networks. Drive DeVilbiss France, Sicat France, and Zephyr Sleep Technologies France contribute with innovative product lines in masks, diagnostic wearables, and software-based platforms. The competitive environment emphasizes patient comfort, digital integration, and home-based solutions, shaping growth strategies across all leading participants.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In May 2025, ResMed acquired VirtuOx, a provider of home sleep testing services. This acquisition aims to enhance ResMed’s diagnostic capabilities and expand its presence in the French market.
In July 2024, Inspire Medical Systems announced that its Inspire therapy for obstructive sleep apnea is now fully reimbursed in France. This development is expected to increase patient access to this treatment option.
In April 2025, Apnimed expanded its portfolio by acquiring global rights to sulthiame from Desitin Arzneimittel GmbH, aiming to develop new oral therapies for sleep apnea and related breathing disorders in Europe.
Report Coverage
The research report offers an in-depth analysis based on Product Type, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for PAP devices will continue to grow due to high treatment efficacy.
Home sleep testing will gain wider adoption supported by patient convenience.
Oral appliances will expand as non-invasive alternatives gain patient acceptance.
Connected health solutions will strengthen remote monitoring and therapy adherence.
Customized and comfortable masks will drive higher patient compliance rates.
Hospitals and clinics will maintain leadership in diagnostics and treatment adoption.
Home care settings will grow faster with the spread of portable devices.
Local manufacturers will focus on affordable solutions to expand rural access.
Partnerships between medtech and digital health firms will accelerate product innovation.
Awareness campaigns will reduce underdiagnosis and expand the treated patient pool.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : SLEEP APNEA DEVICES MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Country-wise Price Trend
3.6.2 Price Trend by Product CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Country-wise Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Application Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Country-wise Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Product Type & End User Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Country
6.1.1. France Sleep Apnea Devices Market Import Volume By Country
6.2. Export Analysis by Country
6.2.1. France Sleep Apnea Devices Market Export Volume By Country CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. France Sleep Apnea Devices Market: Company Market Share
7.1. France Sleep Apnea Devices Market Company Volume Market Share
7.2. France Sleep Apnea Devices Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Country-wise Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : SLEEP APNEA DEVICES MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS
8.1. Sleep Apnea Devices Market Overview by Product Type Segment
8.1.1. Sleep Apnea Devices Market Volume Share By Product Type
8.1.2. Sleep Apnea Devices Market Revenue Share By Product Type
8.2. Therapeutic Devices
8.2.1. Positive Airway Pressure (PAP) Devices
8.2.2. Oral Appliances
8.2.3. Oxygen Therapy Devices
8.2.4. Nasal & Full-Face Masks
8.2.5. Others
8.3. Diagnostic Devices
8.3.1. Polysomnography (PSG) Devices
8.3.2. Home Sleep Test Kits (HST)
8.3.3. Pulse Oximeters
8.3.4. Actigraphy Wearables
8.3.5. Others
8.4. Sleep Apnea Masks
8.5. Others CHAPTER NO. 9 : SLEEP APNEA DEVICES MARKET – BY END USER SEGMENT ANALYSIS
9.1. Sleep Apnea Devices Market Overview by End User Segment
9.1.1. Sleep Apnea Devices Market Volume Share By End User
9.1.2. Sleep Apnea Devices Market Revenue Share By End User
9.2. Hospitals and Clinics
9.3. Sleep Laboratories
9.4. Home Care Settings / Individual Users
9.5. Others CHAPTER NO. 10 : SLEEP APNEA DEVICES MARKET – COUNTRY-WISE ANALYSIS
10.1. Sleep Apnea Devices Market Overview by Country Segment
10.1.1. France Sleep Apnea Devices Market Volume Share By Country
10.1.2. France Sleep Apnea Devices Market Revenue Share By Country
10.1.3. Country
10.1.4. France Sleep Apnea Devices Market Volume By Country
10.1.5. France Sleep Apnea Devices Market Revenue By Country
10.1.6. Product Type
10.1.7. France Sleep Apnea Devices Market Volume By Product Type
10.1.8. France Sleep Apnea Devices Market Revenue By Product Type
10.1.9. End User
10.1.10. France Sleep Apnea Devices Market Volume By End User
10.1.11. France Sleep Apnea Devices Market Revenue By End User CHAPTER NO. 11 : COMPANY PROFILES
11.1. ResMed France
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.3. Financial Overview
11.1.4. Recent Developments
11.1.5. Growth Strategy
11.1.6. SWOT Analysis
11.2. Philips Respironics France
11.3. SomnoMed France
11.4. BMC Medical France
11.5. Inspire Medical Systems France
11.6. Löwenstein Medical France
11.7. LivaNova PLC France
11.8. Sicat France
11.9. Drive DeVilbiss France
11.10. Zephyr Sleep Technologies France
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for France Sleep Apnea Devices Market, and what is its projected size in 2032?
The France Sleep Apnea Devices Market size reached USD 377.95 million in 2024 and is projected to reach USD 650.25 million by 2032, reflecting strong growth.
At what Compound Annual Growth Rate is the France Sleep Apnea Devices Market projected to grow between 2025 and 2032?
The France Sleep Apnea Devices Market is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.53% between 2025 and 2032, driven by increasing demand.
Which France Sleep Apnea Devices Market segment held the largest share in 2024?
Therapeutic devices held the largest share in 2024, capturing nearly 62% of the France Sleep Apnea Devices Market, with Positive Airway Pressure (PAP) devices driving demand.
What are the primary factors fueling the growth of the France Sleep Apnea Devices Market?
Key growth drivers include rising prevalence of sleep apnea, expanding home-based treatment adoption, and technological advancements enhancing comfort, usability, and efficiency of diagnostic and therapeutic devices.
Who are the leading companies in the France Sleep Apnea Devices Market?
Leading companies include ResMed France, Philips Respironics France, SomnoMed France, BMC Medical France, Inspire Medical Systems France, Löwenstein Medical France, LivaNova PLC France, Sicat France, and Zephyr Technologies.
Which region commanded the largest share of the France Sleep Apnea Devices Market in 2024?
Southern France commanded the largest share of the France Sleep Apnea Devices Market in 2024, accounting for 34% share, supported by advanced healthcare infrastructure and higher diagnosis rates.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The sphygmomanometer market size was valued at USD 3.38 billion in 2024 and is anticipated to reach USD 6.54 billion by 2032, at a CAGR of 8.6 % during the forecast period.
The Orthopedic Devices Market size was valued at USD 51.45 billion in 2024 and is anticipated to reach USD 73.17 billion by 2032, at a CAGR of 4.5% during the forecast period.
The temperature modulation devices market size was valued at USD 3.05 billion in 2024 and is anticipated to reach USD 5.06 billion by 2032, at a CAGR of 6.5 % during the forecast period.
The tendon repair market size was valued at USD 2.56 billion in 2024 and is anticipated to reach USD 5.11 billion by 2032, at a CAGR of 9 % during the forecast period.
The Thyroid Cancer Diagnostics Market size was valued at USD 2.86 billion in 2024 and is anticipated to reach USD 4.2 billion by 2032, at a CAGR of 4.9 % during the forecast period.
Refurbished MRI Systems Market size was valued at USD 799.03 million in 2024 and is anticipated to reach USD 1216.99 million by 2032, at a CAGR of 5.4% during the forecast period.
Germany Sleep Apnea Devices Market size was valued at USD 226.51 million in 2018, reached USD 348.72 million in 2024, and is anticipated to reach USD 619.78 million by 2032, growing at a CAGR of 6.94% during the forecast period.
Prostrate Specific Antigen Test Market size was valued at USD 4.63 Billion in 2024 and is anticipated to reach USD 11.23 Billion by 2032, at a CAGR of 11.7% during the forecast period.
Refurbished Medical Imaging Devices Market size was valued USD 16.55 billion in 2024 and is anticipated to reach USD 28.87 billion by 2032, at a CAGR of 7.2% during the forecast period.
The Prosthetic Heart Valves market size was valued at USD 9.5 billion in 2024 and is anticipated to reach USD 21.43 billion by 2032, at a CAGR of 10.7% during the forecast period.
Rehabilitation Equipment Market size was valued USD 20.07 billion in 2024 and is anticipated to reach USD 29.89 billion by 2032, at a CAGR of 5.1% during the forecast period.
The global X-ray detectors market was valued at USD 4 billion in 2024 and is projected to reach USD 5.61 billion by 2032, growing at a CAGR of 5.88% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$2999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
Market Insights
Key Growth Drivers
Market Segmentations:
